Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Legrand Pharma is a prominent Brazilian pharmaceutical company and a key subsidiary of Grupo NC, the largest pharmaceutical conglomerate in Latin America. Founded in 1991 through its acquisition by EMS, the company has grown significantly, achieving an annual revenue exceeding R$ 1 billion. Legrand Pharma offers a diverse portfolio of over 250 products spanning generic drugs, over-the-counter (OTC) medicines, and prescription pharmaceuticals, with a particularly strong presence in ophthalmology, pain management, and respiratory care. Its flagship products include the widely recognized cough syrup Expec and the analgesic Benevran. Headquartered in Hortolândia, São Paulo, the company leverages Grupo NC's extensive manufacturing and R&D infrastructure to deliver high-quality, accessible healthcare solutions across Brazil.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legrand Pharma.